New adamantane derivatives can overcome resistance of infl uenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine

Bulletin of Experimental Biology and Medicine

Volumn 153, Issue 2, 2012, Pages 233-235

  Shibnev, V A ^a   Garaev, T M ^a   Finogenova, M P ^a   Shevchenko, E S ^a   Burtseva, E I ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Adamantane derivatives; Amino acids; Infl uenza A; Remantadine; Resistance

Indexed keywords

1 ADAMANTANE CARBOXYLIC ACID; ADAMANTANE DERIVATIVE; ANTIVIRUS AGENT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 85027947458     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-012-1684-x     Document Type: Article

References (9)

1. E. I. Burtseva, E. S. Shevchenko, I. A. Leneva, et al., Vopr. Virusol., No. 2, 24-29 (2007).
2. D. K. Lvov, E. I. Burtseva, A. G. Prilipov, et al., Ibid., No. 5, 10-14 (2009).
3. V. A. Shibnev, T. M. Garaev, M. P. Finogenova, et al., Ibid., 56, No. 2, 36-39 (2011).
4. S. D. Cady, T. V. Mishanina, and M. Hong, J. Mol. Biol., 385, No. 4, 1127-1141 (2009).
5. F. Hu, W. Luo, and M. Hong, Science, 330, 505-508 (2010)
6. C. Laohpongspaisan, E. Rungrotmongkol, P. Intharathep, et al., J. Chem. Inf. Model, 49, No. 4, 847-852 (2009).
7. W. Luo, R. Mani, and M. Hong, J. Phys. Chem., 111, No. 36, 10,825-10,832 (2007).
8. A. Okada, T. Miura, and H. Takeuchi, Biochemistry, 40, No.20, 6053-6060 (2001).
9. R. M. Pielak, J. R. Schnell, and J. J. Chou, Proc. Natl. Acad. Sc. USA, 106, No. 18, 7379-7384 (2009).